Pathophysiology, Genetics & Classification

Question	Answer
1. What is the most common enzymatic defect responsible for Congenital Adrenal Hyperplasia (CAH), and what percentage of cases does it account for?	21-Hydroxylase deficiency accounts for >90-95% of all cases of Congenital Adrenal Hyperplasia.
2. Name the specific gene mutated in 21-hydroxylase deficiency and specify its exact chromosomal locus.	It is caused by mutations in the CYP21A2 gene, located on the short arm of chromosome 6 at locus 6p21.3.
3. Explain the dual biochemical blocks that occur in classic 21-hydroxylase deficiency.	1. Impaired conversion of 17-hydroxyprogesterone (17-OHP) to 11-deoxycortisol in the glucocorticoid pathway. 2. Impaired conversion of progesterone to 11-deoxycorticosterone in the mineralocorticoid pathway.
4. What is the precise molecular consequence of cortisol deficiency on anterior pituitary hormone regulation?	Loss of negative feedback inhibition by cortisol triggers a massive compensatory hypersecretion of Adrenocorticotropic Hormone (ACTH) by the anterior pituitary.
5. How does elevated ACTH lead to adrenal hyperplasia and androgen excess?	Massive ACTH hyperstimulation drives continuous trophic enlargement of the adrenal cortex and shunts accumulated steroid precursors into the intact adrenal androgen synthetic pathway, producing massive amounts of DHEA, androstenedione, and testosterone.
6. What is the precise embryological and anatomical cause of ambiguous genitalia in 46,XX female fetuses with CAH?	High levels of fetal androstenedione and testosterone virilize the external genitalia in utero between weeks 8 and 14 of gestation, causing clitoromegaly, labial fusion, and formation of a urogenital sinus.
7. What proportion of classic 21-hydroxylase deficiency cases present with the salt-wasting phenotype?	Approximately 75% of patients with classic 21-hydroxylase deficiency present with the salt-wasting form.
8. Detail the exact renal electrolyte and acid-base disturbances seen in salt-wasting CAH.	Profound renal sodium wasting leading to hyponatremia, impaired potassium and hydrogen ion excretion leading to hyperkalemia, and non-anion gap metabolic acidosis due to mineralocorticoid deficiency.
9. Why do patients with CAH develop generalized cutaneous hyperpigmentation?	Excess ACTH shares a common precursor molecule (pro-opiomelanocortin, POMC) with alpha-Melanocyte-Stimulating Hormone (alpha-MSH), which binds to melanocortin-1 receptors on skin melanocytes, stimulating melanin production.
10. Describe Prader Staging Grade III for ambiguous genitalia in CAH.	Marked clitoromegaly resembling a phallus, accompanied by posterior labial fusion and a single urogenital sinus opening located at the base of the phallus.
11. What anatomical features define Prader Staging Grade V?	Complete male phenotypic appearance with a penile urethra at the tip, completely fused labioscrotal folds resembling a scrotum, and bilaterally non-palpable gonads in a 46,XX female.
12. Why are 46,XY male neonates with classic salt-wasting CAH frequently missed at birth compared to 46,XX females?	46,XY males have normal male external genitalia at birth (sometimes with mild scrotal hyperpigmentation or subtle phallic enlargement), lacking the obvious genital ambiguity that prompts early evaluation in 46,XX females.
13. What is the distinct clinical hallmark of 11-beta-hydroxylase deficiency that differentiates it from 21-hydroxylase deficiency?	Hypertension, because the accumulated precursor 11-deoxycorticosterone possesses strong mineralocorticoid agonist activity, causing hypervolemia and secondary suppression of plasma renin activity.
14. What is the genetic inheritance pattern of classic Congenital Adrenal Hyperplasia?	Autosomal recessive inheritance, requiring bi-allelic pathogenic mutations in the culprit gene for phenotypic expression.
*15. What is the molecular mechanism of most CYP21A2* mutations?**	Most mutations arise from deleterious gene conversion events, large deletions, or point mutations resulting from unequal crossing over between the active CYP21A2 gene and the adjacent non-functional CYP21P1 pseudogene.
16. What distinguishes simple virilizing CAH from salt-wasting CAH at the enzymatic level?	Simple virilizing CAH retains roughly 1-2% of residual 21-hydroxylase enzymatic activity, which is sufficient to maintain postnatal mineralocorticoid balance and prevent life-threatening salt wasting, whereas salt-wasting forms have <1% residual activity.
17. Why does lipoid CAH, caused by StAR (Steroidogenic Acute Regulatory protein) mutation, present with both glucocorticoid and mineralocorticoid deficiency along with impaired sex steroid synthesis?	Because the StAR protein is absolutely required for the transport of free cholesterol from the outer to the inner mitochondrial membrane, which is the rate-limiting, obligatory first step for all steroid hormone synthesis in the adrenals and gonads.

Clinical History & Bedside Evaluation

Question	Answer
1. What are the key presenting symptoms of a neonate with salt-wasting CAH during history taking?	Parents typically report poor feeding, lethargy, persistent projectile or non-projectile vomiting, weight loss, and failure to thrive starting around the second week of life.
2. Why is a thorough dietary and feeding history crucial when evaluating a neonate suspected of having CAH?	It helps differentiate salt-wasting CAH from pyloric stenosis or sepsis, as infants with CAH exhibit voracious or poor feeding accompanied by profound lethargy and dehydration out of proportion to vomiting.
3. What specific perinatal history clues should be actively elicited when suspecting CAH in a newborn?	Enquire about consanguinity in parents, family history of unexplained neonatal deaths, sudden infant death syndrome (SIDS), or a previous sibling with ambiguous genitalia or early unexplained shock.
4. What clinical feature in the neonatal history differentiates a 46,XX female infant from a 46,XY male infant with classic salt-wasting CAH?	46,XX females are recognized early due to genital ambiguity (clitoromegaly/labial fusion), whereas 46,XY males have normal male genitalia and are missed until they collapse in acute adrenal crisis.
5. What bedside physical examination findings in the skin warrant an immediate suspicion of CAH in an ill neonate?	Generalized hyperpigmentation, especially pronounced over the areolae, scrotal/labial skin creases, and umbilicus, due to high ACTH and melanocyte-stimulating hormone cross-activation.
6. What bedside assessment of hydration status must be performed immediately in a suspected CAH infant?	Evaluation for signs of severe hypovolemia: sunken anterior fontanelle, dry mucous membranes, reduced skin turgor, delayed capillary refill time (> 3 seconds), and cool extremities.
7. What vital sign abnormalities on bedside evaluation serve as red flags for an impending or established adrenal crisis?	Persistent tachycardia, hypotension or hypovolemic shock, hypothermia (or fever if triggered by sepsis), and tachypnea secondary to metabolic acidosis.
8. What gastrointestinal differential diagnostic red flag in the history must be carefully ruled out when evaluating projectile vomiting in a CAH infant?	Infantile hypertrophic pyloric stenosis, which characteristically presents with hypochloremic metabolic alkalosis, unlike the hyperkalemic metabolic acidosis of salt-wasting CAH.
9. What prenatal history finding on maternal ultrasound might provide a retrospective or prospective red flag for CAH?	Identification of fetal ambiguous genitalia or clitoromegaly during routine second- or third-trimester anomaly scans in families at risk.
10. What predisposing environmental or physiological risk factors can precipitate an acute adrenal crisis in a previously stable mild CAH patient?	Intercurrent infections, gastroenteritis, surgical stress, or severe trauma that dramatically increases cortisol demands.
11. What developmental history milestone is essential to evaluate in older children presenting with late-diagnosed simple virilizing CAH?	Assessment for precocious pseudopuberty: rapid linear growth acceleration in early childhood followed by premature epiphyseal fusion and short adult stature.
12. What specific behavioral or physical complaints in a toddler history might indicate simple virilizing CAH?	Premature pubarche (early appearance of pubic hair, axillary hair, adult body odor, and acne) before 8 years in girls or 9 years in boys.
13. Why is a detailed maternal drug history during pregnancy important when evaluating ambiguous genitalia in a newborn?	To rule out maternal ingestion of exogenous androgens, progestins, or anti-androgens that can phenocopy CAH-induced virilization in female fetuses.
14. What crucial historical red flag distinguishes CAH from congenital hypothyroidism or sepsis in a lethargic neonate?	The presence of salt-wasting dehydration, hyperpigmentation, and electrolyte derangements (hyponatremia with hyperkalemia).
15. VIVA TRAP: Can a breastfed infant with salt-wasting CAH present with normal weight gain in the first week of life?	YES. Initial weight loss in the first 3 to 5 days is physiological, but failure to regain birth weight by day 10–14 combined with progressive lethargy and vomiting signals a salt-wasting crisis.
16. What specific neonatal screening history question must be asked if an infant presents from a state or country with universal newborn screening?	Whether dried blood spot screening for 17-hydroxyprogesterone (17-OHP) was performed and what the results or follow-up status were.
17. What bedside anthropometric parameter evaluation is mandatory in an older child presenting with late-onset non-classic CAH?	Plotting height velocity on growth charts to detect early linear growth acceleration and advanced bone age trajectory.
18. Why does a classic salt-wasting 21-hydroxylase deficiency typically present clinically around the 2nd week of life rather than immediately at birth?	1. The fetus is protected in utero by maternal transplacental passage of cortisol and progesterone. 2. Postnatal clearance of maternal hormones takes 7 to 14 days, after which the infant's own deficient adrenal axis unmasks severe mineralocorticoid and glucocorticoid deficiency.

Physical Examination & Bedside Signs

Question	Answer
1. Where is hyperpigmentation most intensely observed during the physical examination of a neonate with salt-wasting CAH?	Over the areolae, the external genitalia (scrotum in males or labioscrotal folds in females), and skin creases due to melanocyte stimulation by high circulating ACTH and alpha-MSH levels.
2. How do you systematically inspect the labioscrotal folds of a newborn during physical examination to differentiate CAH virilization from cryptorchidism?	1. Inspect for labial fusion or incomplete labioscrotal fusion. 2. Palpate the folds carefully; in CAH (46,XX), both gonads are absent from the labioscrotal folds, whereas bilateral undescended testes in a 46,XY male would feel like palpable gonads.
3. What cardiovascular bedside physical signs indicate that a neonate with CAH has progressed into hypovolemic shock?	Tachycardia out of proportion to fever (or bradycardia in terminal shock), feeble or absent peripheral pulses, prolonged capillary refill, cool and mottled extremities, and hypotension.
4. How is Prader Stage IV ambiguous genitalia specifically recognized on physical inspection?	Marked clitoromegaly resembling a small penis with penile hypospadias, complete fusion of the labioscrotal folds forming a rugated bifid scrotum, and completely empty labioscrotal folds.
5. What bedside neurological sign is frequently elicited when examining a lethargic neonate presenting with acute salt-wasting CAH crisis and severe hyponatremia?	Profound lethargy, hypotonia (floppy infant), depressed or absent neonatal reflexes (moro, suck), and in severe cases of cerebral edema from rapid hyponatremia, high-pitched cry or seizures.
6. What specific physical examination maneuver should be avoided or performed with extreme caution when examining the genitalia of a newborn with suspected CAH?	Rough or aggressive milking of the perineum or probing of the urogenital sinus, which can cause mucosal trauma and introduce infection; genital examination must be gentle and descriptive.
7. What pathognomonic physical inspection finding distinguishes simple virilizing CAH presenting in a 4-year-old child from normal prepubertal growth?	Signs of isosexual pseudoprecocity: significant phallic or clitoromegaly, premature pubarche (pubic and axillary hair), adult body odor, and accelerated linear growth velocity with advanced bone age.
8. What bedside abdominal palpation finding might be elicited in a severely dehydrated infant with CAH presenting with vomiting?	A soft, non-tender abdomen with no palpable organomegaly or olive-shaped mass (ruling out hypertrophic pyloric stenosis, which mimics CAH vomiting).
9. What specific inspection finding in a young female child with late-diagnosed simple virilizing CAH can be seen on perineal examination?	Clitoromegaly with a single perineal opening or a shallow vagina where the urethral and vaginal orifices have failed to separate completely.
10. What bedside sign of muscular or neuromuscular irritability should be actively looked for in an infant with profound hyperkalemia due to salt-wasting CAH?	While severe hyperkalemia typically causes generalized weakness and hypotonia, cardiac auscultation may reveal arrhythmias or bradycardia as an indirect sign of cardiotoxicity.
11. What auscultatory finding on cardiovascular examination is expected in a neonate in hypovolemic shock secondary to an adrenal crisis?	Tachycardia with muffled or faint heart sounds and gallop rhythm due to impaired myocardial contractility resulting from acute mineralocorticoid and glucocorticoid deficiency.
12. What specific skin texture sign is associated with the chronic dehydration and electrolyte imbalance of untreated or partially treated salt-wasting CAH?	Dry, thick, inelastic skin with a characteristic grayish-brown hyperpigmentation and poor tissue turgor.
13. How does the body proportion (upper to lower segment ratio) appear on physical examination of an older child with poorly controlled long-standing CAH?	Premature epiphyseal fusion due to early excess adrenal androgens leads to short adult stature with relatively long arms and legs (eunuchoid proportions are absent; instead, stocky build with early growth cessation).
14. VIVA TRAP: Can you definitively differentiate a 46,XX female with severe CAH (Prader V) from a normal 46,XY male by physical examination of the external genitalia alone?	NO. Prader Grade V virilization results in a completely male-appearing phallus and fused scrotum with bilaterally non-palpable testes, which is indistinguishable on inspection alone from a 46,XY male with bilateral cryptorchidism and hypospadias.
15. What specific bedside assessment sign differentiates the dehydration of CAH salt-wasting crisis from acute gastroenteritis in an infant?	CAH infants present with profound hypovolemic shock and hyponatremic dehydration with striking hyperpigmentation and ambiguous genitalia (in females), whereas gastroenteritis typically shows signs of acute fluid loss without genital anomalies or hyperpigmentation.
16. What physical sign on respiratory examination might be appreciated in a neonate with CAH experiencing severe metabolic acidosis during a salt-wasting crisis?	Kussmaul breathing, characterized by deep, rapid, labored respirations attempting to compensate for severe non-anion gap metabolic acidosis.
17. What specific physical examination signs of cutaneous hyperpigmentation should an examiner look for in a neonate with classic Congenital Adrenal Hyperplasia, and what is their underlying pathophysiological trigger?	1. The examiner should inspect for noticeable hyperpigmentation over the areolae, external genitalia, and deep skin creases. 2. This sign is driven by massive compensatory secretion of Adrenocorticotropic Hormone (ACTH) resulting from glucocorticoid deficiency; ACTH shares an identical amino acid sequence with alpha-Melanocyte-Stimulating Hormone (alpha-MSH), which directly stimulates cutaneous melanocytes.

Diagnostic Criteria & Investigations

Question	Answer
1. Why must interpretation of baseline 17-OHP levels in a neonate account for gestational age and postnatal age?	Premature infants and stressed newborns have physiologically higher baseline 17-OHP levels, requiring age- and birth-weight-specific normative cutoff nomograms to avoid false positives.
2. What confirmatory dynamic stimulation test is utilized when baseline 17-OHP levels are equivocal or in non-classic CAH?	The short ACTH stimulation test (Cosyntropin test at 0.25 mg IV/IM); a stimulated 17-OHP level exceeding 10 ng/mL (30 nmol/L) at 60 minutes confirms 21-hydroxylase deficiency.
3. What are the characteristic baseline serum electrolyte abnormalities diagnostic of the salt-wasting form of CAH?	Hyponatremia (serum sodium < 130 mEq/L) and hyperkalemia (serum potassium > 5.5 to 6.0 mEq/L) appearing between day 7 and 14 of life.
4. What acid-base status abnormality is typically documented on the venous or arterial blood gas of an infant in acute salt-wasting crisis?	High anion gap or normal anion gap metabolic acidosis secondary to renal tubular dysfunction and tissue hypoperfusion, with lowered serum bicarbonate (< 15 mEq/L).
5. What plasma hormonal profile other than 17-OHP is diagnostic when evaluating suspected non-classic or atypical forms of CAH?	Elevated early morning basal serum 17-OHP, androstenedione, and testosterone levels, coupled with an elevated ratio of 17-OHP to cortisol after ACTH stimulation.
*6. What is the gold standard genetic diagnostic modality used to identify mutations in the CYP21A2* gene?**	Multiplex ligation-dependent probe amplification (MLPA) or allele-specific PCR to detect large deletions, gene conversions, and point mutations on chromosome 6p21.3.
7. What imaging modality is preferred as the initial non-invasive investigation to evaluate internal pelvic reproductive organs in a 46,XX infant with ambiguous genitalia?	Pelvic ultrasonography to visualize the presence or absence of a uterus, cervix, vagina, and normal or non-visualized gonads (testes vs. ovaries).
8. What specific radiological procedure is considered the gold standard for defining urogenital sinus anatomy and vaginal pouch insertion prior to surgical correction?	Urogenitography (contrast genitogram) combined with cystoscopy and vaginoscopy under anesthesia.
9. What hematological laboratory abnormality is frequently seen on complete blood counts in infants undergoing severe acute adrenal crisis?	Normocytic or macrocytic anemia and relative neutropenia, sometimes accompanied by relative lymphocytosis due to mineralocorticoid and glucocorticoid withdrawal.
10. What biochemical finding differentiates primary adrenal insufficiency (CAH) from secondary adrenal insufficiency?	Markedly elevated baseline plasma ACTH levels (> 100 pg/mL up to thousands) in primary CAH, contrasted with low or inappropriately normal ACTH in secondary adrenal deficiency.
11. What specific plasma steroid precursor besides 17-OHP is elevated in 11-beta-hydroxylase deficiency CAH?	11-Deoxycortisol and 11-Deoxycorticosterone (DOC), which drive mineralocorticoid excess leading to hypertension and hypokalemia.
12. What serum biomarker cutoff for basal 17-OHP is universally accepted for newborn screening (NBS) programs using dried blood spot (DBS) tandem mass spectrometry?	Cutoffs vary by birth weight and gestational age, but a DBS 17-OHP > 20 to 30 ng/mL on initial screening warrants immediate recall and confirmatory serum testing.
13. What biochemical parameter confirms adequate mineralocorticoid replacement therapy during follow-up monitoring of treated CAH patients?	Normalization of serum electrolytes (sodium and potassium) and plasma renin activity (PRA) maintained in the upper half of the normal reference range.
14. What diagnostic imaging finding on an abdominal ultrasound is characteristic of the adrenal glands in classic CAH?	Enlarged, cerebriform, or bulky adrenal glands with preserved normal triangular or reniform shape, maintaining striking neonatal fetal zone visibility.
15. VIVA TRAP: Can a normal newborn screening dried blood spot (DBS) for 17-OHP completely rule out classic Congenital Adrenal Hyperplasia?	NO. False-negative DBS screens occur in premature infants, low birth weight neonates, or due to delayed rise of precursors, meaning symptomatic infants must have serum testing regardless of NBS results.
16. What specialized diagnostic assay is required to differentiate 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD) deficiency from 21-hydroxylase deficiency?	Elevated ratios of 17-hydroxypregnenolone to 17-hydroxyprogesterone and dehydroepiandrosterone (DHEA) to androstenedione on steroid profiling.
17. What specific urinary steroid metabolite analysis technique has largely replaced older 17-ketosteroid measurements for specialized CAH diagnosis?	Gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) profile analysis of urinary steroid metabolites.
18. What is the gold standard confirmatory endocrine diagnostic test and diagnostic threshold value used to establish classic 21-hydroxylase deficiency Congenital Adrenal Hyperplasia in a neonate?	1. The gold standard diagnostic test is a Serum 17-Hydroxyprogesterone (17-OHP) measurement, ideally obtained via tandem mass spectrometry (LC-MS/MS). 2. In a term neonate after the first 24 to 48 hours of life, a basal 17-OHP level exceeding 10,000 ng/dL (or > 300 nmol/L) is diagnostic for classic Congenital Adrenal Hyperplasia. 3. For ambiguous borderline values or suspected non-classic forms, an ACTH stimulation test (cosyntropin 0.25 mg or 15 mcg/kg) demonstrating a stimulated 17-OHP response greater than 1,000 ng/dL (30 nmol/L) at 60 minutes confirms the diagnosis.

Evidence-Based Management & Pharmacotherapy

Question	Answer
1. What is the stat intravenous glucocorticoid bolus dosage and agent of choice for managing an acute adrenal crisis in a newborn with CAH?	1. IV Hydrocortisone (cortisol) is the drug of choice given its combined glucocorticoid and weak mineralocorticoid activity. 2. Administer a stat bolus dose of 50 to 100 mg/m^2 (or 25 to 50 mg absolute dose in a neonate) via IV push.
2. How should maintenance glucocorticoid therapy be administered after the acute stabilization phase in a classic CAH infant?	1. Administer oral Hydrocortisone at a physiological replacement dose of 10 to 15 mg/m^2/day. 2. Divide the total daily dose into three equal portions given every 8 hours to mimic diurnal cortisol secretion and prevent growth suppression.
3. What is the standard starting oral dosage and mechanism of mineralocorticoid replacement in infants diagnosed with salt-wasting CAH?	1. Oral Fludrocortisone acetate is initiated at 0.1 to 0.2 mg daily, often divided into twice-daily dosing in early infancy. 2. It acts on the mineralocorticoid receptors in the distal renal tubules to promote sodium and water reabsorption while enhancing potassium and hydrogen excretion.
4. When is oral sodium chloride supplementation mandatory, and what is the typical daily dosage for a salt-wasting CAH neonate?	1. Mandatory during infancy because breast milk and standard infant formulas contain insufficient sodium to balance renal losses. 2. Prescribe 1 to 2 grams (17 to 34 mEq) of supplemental sodium chloride per day, divided into multiple feeds.
5. What is the emergency "stress dosing" rule for hydrocortisone during acute febrile illness, gastroenteritis, or minor trauma in a known CAH child?	1. Triplicate the maintenance oral hydrocortisone dose (triple dose / 3x rule) for the duration of the febrile illness or acute stress. 2. Instruct parents that if the child vomits within 30 minutes of oral administration, the dose must be repeated immediately.
6. What pharmacological protocol must be followed when a child with CAH requires emergency surgery or major trauma care?	1. Administer IV Hydrocortisone perioperatively as a stress bolus (50 to 100 mg/m^2) just prior to anesthesia induction. 2. Continue high-dose IV hydrocortisone every 6 to 8 hours postoperatively at stress levels until oral intake and baseline health are fully restored.
7. What is the primary mechanism of action of Hydrocortisone when used at pharmacological doses to treat the virilizing component of CAH?	1. High physiological or slightly supraphysiological doses restore negative feedback to the hypothalamus and anterior pituitary. 2. This suppresses excessive ACTH secretion, thereby shutting down the overactive adrenal androgen synthetic pathways.
8. Why is Dexamethasone generally avoided as a routine daily maintenance glucocorticoid in growing infants and children with CAH?	1. Dexamethasone is a long-acting glucocorticoid with potent receptor binding and a very long half-life. 2. Routine daily use in children frequently causes severe iatrogenic Cushing syndrome, linear growth arrest, obesity, and adrenal suppression.
9. What specific emergency medication and administration route must every family of a child with salt-wasting CAH carry at all times?	1. Injectable Hydrocortisone sodium succinate (Solu-Cortef) or Hydrocortisone phosphate for emergency intramuscular (IM) or subcutaneous injection. 2. Parents must be formally trained to administer an emergency IM dose (25 to 50 mg) when oral intake is impossible due to intractable vomiting or shock.
10. What is the primary therapeutic goal of adding mineralocorticoid therapy to glucocorticoids in classic CAH management?	1. To normalize plasma renin activity (PRA) to the upper limit of the normal range while maintaining normal serum sodium and potassium. 2. Overtreatment with fludrocortisone suppresses PRA and causes hypertension, whereas undertreatment leads to persistent hyperreninemia and salt-wasting.
11. What specific biochemical parameter and clinical sign are monitored to adjust Fludrocortisone dosage during follow-up visits?	1. Plasma Renin Activity (PRA) is the most sensitive biochemical marker for adjusting mineralocorticoid replacement. 2. Clinically, monitor blood pressure, dependent edema, and electrolyte levels (serum sodium and potassium).
12. What are the key biochemical markers monitored in the outpatient clinic to assess overall adequacy of glucocorticoid therapy in CAH?	1. Serum 17-hydroxyprogesterone (17-OHP), androstenedione, and total testosterone levels. 2. Avoid chasing completely normal 17-OHP levels, as this invariably requires supraphysiological hydrocortisone doses that cause iatrogenic Cushingoid features and short stature.
13. What are the major long-term adverse effects of chronic supraphysiological glucocorticoid therapy in growing children with CAH?	1. Centripetal obesity, weight gain, hypertension, insulin resistance, and metabolic syndrome. 2. Impaired linear growth velocity resulting in reduced final adult height and decreased bone mineral density (osteopenia/osteoporosis).
14. What are the definitive surgical indications and timing considerations for feminizing genitoplasty in a 46,XX female infant with severe CAH (Prader III-V)?	1. Performed selectively by experienced pediatric urologists/surgeons, ideally between 2 to 6 months of life. 2. Goals include clitoroplasty, marsupialization of the urogenital sinus, and vaginoplasty to allow unobstructed urinary drainage and future sexual/reproductive function.
15. What long-term reproductive endocrine complication frequently occurs in adolescent and adult females with poorly controlled CAH?	1. Hyperandrogenism causes secondary amenorrhea, oligomenorrhea, hirsutism, and anovulation mimicking Polycystic Ovary Syndrome (PCOS). 2. Chronic adrenal rest tumors in the ovaries or testes can also develop and impair fertility if long-term disease control is suboptimal.
16. What specialized surveillance is mandatory in post-pubertal males with classic CAH to detect Testicular Adrenal Rest Tumors (TART)?	1. Regular scrotal ultrasonography starting in late adolescence or early adulthood. 2. TARTs are benign lesions driven by chronic high ACTH stimulation that can cause mechanical testicular obstruction and infertility, responsive to intensive glucocorticoid optimization.
17. VIVA TRAP: Should Fludrocortisone supplementation be routinely tapered and discontinued after the first year of life because infants tolerate salt better?	1. NEVER. 2. Salt-wasting classic CAH is a lifelong condition requiring permanent mineralocorticoid replacement alongside glucocorticoids, although absolute sodium chloride powder supplementation can often be discontinued once table foods are introduced.
18. What specific bone health surveillance and supportive pharmacotherapy are indicated in adolescents with chronic CAH receiving glucocorticoids?	1. Periodic dual-energy X-ray absorptiometry (DEXA) scans to evaluate bone mineral density. 2. Ensure adequate dietary calcium, vitamin D supplementation, and rigorous optimization of disease control to prevent chronic glucocorticoid-induced bone loss.
19. What is the recommended management protocol when an adolescent female with CAH presents with persistent anovulation and severe hirsutism despite standard glucocorticoid doses?	1. Optimize glucocorticoid and mineralocorticoid compliance first to suppress adrenal androgen overproduction. 2. Add adjunctive anti-androgens (such as spironolactone or flutamide) and combined oral contraceptives after consultation with a pediatric endocrinologist.

High-Yield VIVA TRAPs & Examiner Pitfalls

Question	Answer
1. VIVA TRAP: Can Ringer's Lactate solution be safely used for fluid resuscitation in an infant presenting with acute salt-wasting CAH crisis?	NEVER. Ringer's Lactate contains potassium (4 mEq/L), which is strictly contraindicated because infants with acute salt-wasting CAH are already suffering from life-threatening hyperkalemia that can trigger fatal cardiac arrhythmias; use 0.9% Normal Saline with 5% or 10% Dextrose instead.
2. VIVA TRAP: Should you ever delay IV Hydrocortisone administration in a suspected CAH salt-wasting crisis while waiting for laboratory confirmation of serum electrolytes and 17-OHP?	NEVER. Delaying treatment for lab confirmation is fatal; suspected acute adrenal crisis mandates immediate stat IV Hydrocortisone and fluid resuscitation based purely on clinical presentation.
3. VIVA TRAP: Can a clinician safely discontinue Fludrocortisone replacement therapy in a child with salt-wasting CAH once they transition to a solid food diet containing table salt?	NEVER. Mineralocorticoid dependency for renal sodium conservation and potassium excretion persists life-long in classic salt-wasting CAH, and discontinuing Fludrocortisone will precipitate a lethal adrenal crisis regardless of dietary salt intake.
4. VIVA TRAP: Is it appropriate to use Spironolactone to manage hyperkalemia in an infant experiencing an acute salt-wasting crisis due to 21-hydroxylase deficiency?	NEVER. Spironolactone is a competitive aldosterone receptor antagonist; administering it to a patient with primary mineralocorticoid deficiency and hyperkalemia will dangerously worsen renal salt wasting and hyperkalemia.
5. VIVA TRAP: Can an adolescent female with CAH who presents with irregular menses and elevated 17-OHP be managed by simply doubling her daily hydrocortisone dose?	NO. Simply increasing daily maintenance hydrocortisone leads to supraphysiological exposure, iatrogenic Cushing syndrome, and growth arrest; poor control requires optimizing compliance, splitting doses, or adding a short-acting glucocorticoid/mineralocorticoid adjustment rather than chronic high-dose replacement.
6. VIVA TRAP: Is prophylactic bilateral adrenalectomy indicated as a routine management strategy for all female infants born with severe Prader V ambiguous genitalia due to CAH?	NEVER. Bilateral adrenalectomy creates permanent, life-long dependency on exogenous glucocorticoid and mineralocorticoid replacement with high risks of acute crisis and Addisonian mortality; medical management combined with modern reconstructive genitoplasty is the standard approach.
7. VIVA TRAP: Should neonatal screening dried blood spot 17-OHP cutoffs be standardized universally across all birth weights without adjusting for prematurity?	NO. Premature and low birth weight infants have physiologically immature hypothalamic-pituitary-adrenal axes and high baseline precursor levels, demanding gestational-age-specific or birth-weight-specific cutoff matrices to prevent massive rates of false-positive screens.
8. VIVA TRAP: Can topical potent corticosteroids be applied extensively to treat diaper dermatitis in a neonate with undiagnosed classic CAH without systemic consequences?	NO. Systemic absorption of potent topical steroids combined with underlying unrecognized cortisol deficiency can precipitate an acute adrenal crisis and profound hypoglycemia in an undiagnosed salt-wasting CAH neonate.
9. VIVA TRAP: Is it clinically acceptable to withhold "stress-dose" hydrocortisone when a known CAH child presents with a simple viral upper respiratory infection running a mild fever?	NO. Any febrile illness, vomiting, or physiological stressor impairs cortisol response and requires immediate tripling or quadrupling of the maintenance hydrocortisone dose (oral stress dosing) to prevent precipitating an acute adrenal crisis.
10. VIVA TRAP: Should postnatal prophylactic Dexamethasone be administered to pregnant mothers carrying a known female fetus at risk for CAH prior to genetic confirmation?	NEVER. Prenatal dexamethasone treatment is experimental, highly controversial, and associated with adverse maternal and fetal neurodevelopmental outcomes; it should only be performed under strict institutional review board protocols when indicated.
11. VIVA TRAP: Can Testicular Adrenal Rest Tumors (TART) in post-pubertal males with CAH be successfully treated by performing radical orchidectomy?	NEVER. TARTs are benign hyperplastic masses of ectopic adrenal rest tissue driven by chronic elevated ACTH; they respond to optimizing ACTH suppression via increased glucocorticoid/mineralocorticoid therapy, not surgical removal, unless malignant transformation or complete testicular architectural destruction is proven.
12. VIVA TRAP: Is routine biochemical monitoring of serum 17-OHP levels the sole parameter required to adjust daily hydrocortisone dosage in growing children with CAH?	NO. Serum 17-OHP fluctuates widely throughout the day and relies on clinical parameters like linear growth velocity, bone age advancement, weight gain, and physical exam findings rather than isolated precursor values.
13. VIVA TRAP: Can an infant with classic CAH receive routine live viral attenuated vaccines (such as MMR or Varicella) during an active episode of salt-wasting crisis?	NEVER. Live viral vaccines are strictly contraindicated during any acute metabolic crisis, critical illness, or severe systemic compromise until the patient is fully stabilized, resuscitated, and clinically recovered.
14. VIVA TRAP: Is metyrapone therapy utilized as a primary first-line monotherapy to treat classic 21-hydroxylase deficiency CAH in neonates?	NEVER. Metyrapone blocks 11-beta-hydroxylase, which further inhibits cortisol synthesis and aggravates precursor shunting and mineralocorticoid deficiency; it has no role as monotherapy in 21-hydroxylase deficiency.
15. VIVA TRAP: Should diagnostic evaluation for 21-hydroxylase deficiency be omitted in a phenotypic 46,XY male infant who presents with normal male external genitalia and shock?	NEVER. 46,XY males with salt-wasting CAH have normal male genitalia, lacking the ambiguous genitalia cue seen in females; therefore, any neonate presenting with unexplained hyponatremia and hyperkalemia must be screened for CAH regardless of sex.
16. VIVA TRAP: Can a clinician rely exclusively on a normal basal serum cortisol level drawn at 8:00 AM to completely exclude non-classic (late-onset) CAH?	NO. Basal cortisol levels can be entirely normal in non-classic CAH; diagnosis requires demonstrating an exaggerated 17-OHP response following an ACTH stimulation test or performing targeted molecular genetic testing.
17. VIVA TRAP: Can human chorionic gonadotropin (hCG) stimulation testing be safely performed during the first two weeks of life to differentiate CAH from male pseudohermaphroditism in a virilized 46,XX infant?	NEVER. 1. 46,XX females have no testicular tissue, making hCG stimulation completely useless and diagnostically misleading. 2. In a newborn presenting with ambiguous genitalia, karyotyping and serum 17-hydroxyprogesterone are the mandatory first-line investigations, not provocative testicular stimulation tests.
18. VIVA TRAP: Should you interpret an elevated newborn screening dried blood spot 17-hydroxyprogesterone value in a premature infant using the exact same absolute cutoff threshold applied to a full-term infant?	NO. 1. Premature and low-birth-weight infants physiologically exhibit markedly elevated serum 17-hydroxyprogesterone levels due to transient immaturity of the hypothalamic-pituitary-adrenal axis and enzyme pathways, leading to high false-positive rates. 2. Newborn screening laboratories must apply gestational-age-specific and birth-weight-specific reference cutoffs, and borderline results require prompt repeat dried blood spot screening or serum confirmatory testing.